Financials
- Market Capitalization 1.82 B
- Employee 264
- Founded 2003
- CEO Kenneth Galbraith
- Website www.zymeworks.com
- Headquarter Delaware, United States
- FIGI BBG019XSYC89
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-24.38
売上高対価格比率
18.74
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2047 | STOK Stoke Therapeutics, Inc. - Common Stock | 29.66 USD | +0.68% | -11.78% | -2.72% | +144.92% | 1.85 B USD | ||
| 2054 | PGEN Precigen, Inc. - Common Stock | 5.14 USD | -0.58% | -7.72% | +11.74% | +162.24% | 1.83 B USD | ||
| 2075 | AAPG Ascentage Pharma Group International - American Depository Shar | 19.18 USD | -2.24% | +2.62% | +6.73% | -23.28% | 1.79 B USD | ||
| 2080 | IOVA Iovance Biotherapeutics, Inc. - Common Stock | 3.99 USD | -1.24% | -5.45% | -3.16% | +111.11% | 1.78 B USD |